T. Arngrim

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Ylva Ginsberg, T. Tvedten, T. Arngrim et al. · Advances in Therapy · 2013 · 64 citations · Full text

Medicine, Pharmacology, Psychiatry +12

Outcome of lithium prophylaxis: a prospective follow‐up of affective disorder patients assigned to high and low serum lithium levels

Peter Vestergaard, Rasmus Wentzer Licht, A. Brodersen et al. · Acta Psychiatrica Scandinavica · 1998 · 62 citations

Medicine, Pharmacotherapy, Psychiatry +9

Taking Charge of Adult ADHD

T. Arngrim · Acta Psychiatrica Scandinavica · 2011 · 32 citations

Medicine, Behavioral Sciences, Psychiatry +8

Correlation of symptomatic improvements with functional improvements and patient-reported outcomes in adults with attention-deficit/hyperactivity disorder treated with OROS methylphenidate

Michael Rösler, Ylva Ginsberg, T. Arngrim et al. · The World Journal of Biological Psychiatry · 2011 · 29 citations

Medicine, Health Sciences, Psychiatry +17

Long-Term (1 Year) Safety and Efficacy of Methylphenidate Modified-Release Long-Acting Formulation (MPH-LA) in Adults with Attention-Deficit Hyperactivity Disorder: A 26-Week, Flexible-Dose, Open-Label Extension to a 40-Week, Double-Blind, Randomised, Placebo-Controlled Core Study

Ylva Ginsberg, T. Arngrim, Alexandra Philipsen et al. · CNS Drugs · 2014 · 19 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14